Skip to main content
MDAI
NASDAQ Industrial Applications And Services

Shareholders Approve Potential Highly Dilutive Share Issuance to Hudson Bay

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$2.03
Mkt Cap
$64.603M
52W Low
$1.18
52W High
$3.21
52W Position info
72% above low
Off High info
37% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

MDAI sits 72% above its 52-week low of $1.18.

Summary

Spectral AI shareholders approved the authorization for a potentially highly dilutive share issuance to Hudson Bay Master Fund Ltd., which could result in approximately 25% dilution if fully utilized, providing a capital pathway but raising concerns about shareholder value.


Key Events · Financing and Capital Events · MDAI

  • Shareholder Approval for Hudson Bay Issuance

    Stockholders approved the authorization to issue up to 8 million common shares to Hudson Bay Master Fund Ltd. under a Securities Purchase Agreement dated October 24, 2025. This approval, previously sought via a PRE 14A on April 6, 2026, enables a significant capital raise but carries substantial potential dilution of approximately 25%.

  • Re-election of Directors

    Five directors, including Chairman J. Michael DiMaio, were re-elected to the Board for a one-year term expiring at the 2027 Annual Meeting of stockholders.

  • Auditor Ratification

    Forvis Mazars LLP was ratified as the independent registered public accounting firm for fiscal year 2026.

  • Commercialization Outlook Provided

    The company reiterated recent FDA De Novo Classification for its DeepView System (announced May 26, 2026) and outlined anticipated commercial sales by year-end 2026, alongside other operational milestones.


Analysis · MDAI · Industrial Applications And Services

Shareholders have approved the authorization to issue up to 8 million common shares to Hudson Bay Master Fund Ltd. This approval enables the company to proceed with a financing arrangement that, if fully utilized, could result in approximately 25% dilution for existing shareholders based on current outstanding shares. While this provides a pathway for capital, it raises concerns about shareholder value, especially following a recent quarter with increased cash burn.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MDAI was trading at $2.03 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $64.6M. The 52-week trading range was $1.18 to $3.21. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MDAI - Latest Insights

MDAI
Nov 16, 2026, 4:08 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.31
Real-time Price: $1.33 info
Change: +$0.020 (+2%) info
Market Cap: $42.806M info
MDAI
Nov 10, 2026, 5:43 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1.32
Real-time Price: $1.33 info
Change: +$0.010 (+0.76%) info
Market Cap: $42.806M info
MDAI
Sep 15, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.59
Real-time Price: $1.33 info
Change: -$0.260 (-16%) info
Market Cap: $42.806M info
MDAI
Aug 11, 2026, 4:02 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.63
Real-time Price: $1.33 info
Change: -$0.300 (-18%) info
Market Cap: $42.806M info
MDAI
Jul 08, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.73
Real-time Price: $1.33 info
Change: -$0.400 (-23%) info
Market Cap: $42.806M info